MedTrace Logo

Trial Comparing Treatment of Tretinoin or Superficial Dermabrasion for Stretch Marks

NCT01027793 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2021-01-22

Study results available
· View outcomes & findings →

Summary

This study aims to evaluate head-to-head the effectiveness of tretinoin 0.5% and superficial dermabrasion in subjects that have recent stretch marks.

Conditions

  • Stretch Marks
  • Striae
  • Treatment

Interventions

DRUG

Tretinoin cream 0.005%

Group 1 will receive tretinoin cream 0.05%(Vitanol A, Stiefel) that should be applied daily in areas affected by stretch marks, in both sides, for a period of 16 weeks.

DEVICE

Superficial Dermabrasion

Group 2 will receive 16 sessions of dermabrasion that would be held in the research center

Sponsors & Collaborators

  • Brazilan Center for Studies in Dermatology

    lead OTHER

Principal Investigators

  • Doris M Hexsel, MD · Brazilian Center For Studies in Dermatology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
25 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01027793 on ClinicalTrials.gov